Small Ankyrin-1 and Obscurin as a Model for Ankyrin Binding Motifs
Willis, Chris
Author
Advisor
Date
Embargo until
Language
Book title
Journal
Publisher
Peer Reviewed
Type
Research Area
Jurisdiction
Files
Other Titles
See at
Abstract
Small ankyrin-1 binds with high affinity to two regions within obscurin A. This interaction provides a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscle. Here, I show that four hydrophobic residues within the hydrophobic "hotspot" of the ankyrin-like repeats of sAnk1 are involved in binding obscurin. Alanine scanning mutagenesis of each of the four residues inhibits binding to the high affinity binding site, Obsc6316-6345, whereas two of the mutations had no effect on binding to the lower affinity site, Obsc6231-6260. Mutagenesis identified three central residues within Obsc6316-6345 that are critical for binding sAnk1, but no single residue within Obsc6231-6260 that is essential. Instead, only a triple mutant of neighboring residues of Obsc6231-6260 decreases binding. This suggests the positional importance of the hydrophobic residues within the central region of Obsc6316-6345 that have a direct role in docking to sAnk1, in contrast to a more general, hydrophobic contribution of the hydrophobic residues of Obsc6231-6260. Modeling of sAnk1 and Obsc6316-6345 are consistent with the idea that specific hydrophobic residues interact in the docked complex. Using the identified hydrophobic and previously reported charged amino acids of obscurin involved in binding, I identify two classes of ankyrin binding motifs (ABMs) The first, type 1, contains ~35% alpha-helix, between two less structured regions. The second, type 2, contains~17% alpha-helix at its amino-terminal, flanked by a disordered carboxy-terminal sequence. Using a custom matrix, I classify several known ABMs as type 1 or 2 by structural comparison and sequence alignment within the ABM-specific matrix. I use this matrix to predict ABMs in proteins that bind ankyrins. This method identified a type 1 ABM in histone deacetylase-4 and in retinoblastoma protein that bind their ligands, RFXAnk and gankyrin, respectively. I confirm this binding with in vitro assays and the ~30% helical content of retinoblastoma by circular dichroism. The method also identified a type 2 ABM in the retinoblastoma protein that binds gankyrin in vitro and has ~15% helical content. I conclude that my methods can be used to predict ABMs from primary sequence which will be applicable to the prediction of other protein-protein interactions.
